Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Diebold sees FY20 revenue $3.7B-$3.9B, consensus $3.78B » 07:09
06/22/20
06/22
07:09
06/22/20
07:09
DBD

Diebold

$5.97 /

+0.52 (+9.54%)

Outlook for FY20…

Outlook for FY20 includes: Revenue of $3.7B-$3.9B which includes YoY foreign currency headwinds of approximately $120M and divestiture impacts of approximately $80M. Adjusted EBITDA in the range of $400M-$440M an increase of up to 10% versus 2019 results. The company continues to target approximately $130M in gross savings from its DN Now transformation initiatives, plus incremental cost savings of $80M-$100M which is comprised of both recurring and one-time savings. Break-even free cash flow.

ShowHide Related Items >><<
DBD Diebold
$5.97 /

+0.52 (+9.54%)

DBD Diebold
$5.97 /

+0.52 (+9.54%)

05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
DBD Diebold
$5.97 /

+0.52 (+9.54%)

DBD Diebold
$5.97 /

+0.52 (+9.54%)

DBD Diebold
$5.97 /

+0.52 (+9.54%)

Earnings
Diebold reports preliminary YTD revenue of $1.4B, down 17.4% y/y » 07:07
06/22/20
06/22
07:07
06/22/20
07:07
DBD

Diebold

$5.97 /

+0.52 (+9.54%)

Diebold Nixdorf reported…

Diebold Nixdorf reported preliminary financial results through May: Non-GAAP operating profit of $106.9M increased $51.5M or 93.3% YoY, as a result of higher-quality revenue and the positive effects of DN Now transformation initiatives. Adjusted EBITDA of $149.7M increased $34M, or 29.4% YoY. Free cash use of $176M increased by $22 million as compared with free cash use of $154M in the prior-year period. Revenue of $1.4B declined by 17.4%, or $303M, YoY resulting primarily from approximately $124M of net unplanned reductions related to COVID-19 delays and approximately $98M of net planned reductions. Gerrard Schmid, Diebold Nixdorf president and CEO, said: "Our year-to-date results through May demonstrate the resiliency of our business during the COVID-19 pandemic and solid execution of our DN Now transformation initiatives. In this challenging environment, non-GAAP operating profit of $107M increased $52M versus the same period of 2019. This strong performance provides the confidence to re-establish financial guidance for 2020 as we prepare to meet with a number of investors this week."

ShowHide Related Items >><<
DBD Diebold
$5.97 /

+0.52 (+9.54%)

DBD Diebold
$5.97 /

+0.52 (+9.54%)

05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
DBD Diebold
$5.97 /

+0.52 (+9.54%)

DBD Diebold
$5.97 /

+0.52 (+9.54%)

DBD Diebold
$5.97 /

+0.52 (+9.54%)

Hot Stocks
Diebold partners with Austria's bank99 for ATM network enhancement » 09:00
06/10/20
06/10
09:00
06/10/20
09:00
DBD

Diebold

$6.37 /

-1.04 (-14.04%)

Diebold signed a six-year…

Diebold signed a six-year ATM as a Service agreement with bank99, Austrian Post's new banking and financial services entity, valued at more than $20M, to support a greenfield approach to set up and manage a new digital branch network from end-to-end. Diebold is partnering with bank99 of Austria to set up and manage its entire digital self-service network Bank99 was launched in April as a result of a joint venture between Austrian Post and the GRAWE Banking Group to offer enhanced services including cash recycling systems, customer service terminals and cash dispensing ATMs to postal and branch customers.

ShowHide Related Items >><<
DBD Diebold
$6.37 /

-1.04 (-14.04%)

DBD Diebold
$6.37 /

-1.04 (-14.04%)

05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
DBD Diebold
$6.37 /

-1.04 (-14.04%)

DBD Diebold
$6.37 /

-1.04 (-14.04%)

DBD Diebold
$6.37 /

-1.04 (-14.04%)

Over a month ago
Conference/Events
Diebold participates in a conference call hosted by Sidoti. » 04:55
06/03/20
06/03
04:55
06/03/20
04:55
DBD

Diebold

$5.25 /

-0.35 (-6.25%)

Conference call with…

Conference call with management to be held on June 3 hosted by Sidoti.

ShowHide Related Items >><<
DBD Diebold
$5.25 /

-0.35 (-6.25%)

DBD Diebold
$5.25 /

-0.35 (-6.25%)

05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
DBD Diebold
$5.25 /

-0.35 (-6.25%)

DBD Diebold
$5.25 /

-0.35 (-6.25%)

DBD Diebold
$5.25 /

-0.35 (-6.25%)

Conference/Events
Diebold participates in a conference call hosted by Sidoti. » 11:58
06/01/20
06/01
11:58
06/01/20
11:58
DBD

Diebold

$5.33 /

+0.535 (+11.16%)

Conference call with…

Conference call with management to be held on June 3 hosted by Sidoti.

ShowHide Related Items >><<
DBD Diebold
$5.33 /

+0.535 (+11.16%)

DBD Diebold
$5.33 /

+0.535 (+11.16%)

05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
DBD Diebold
$5.33 /

+0.535 (+11.16%)

DBD Diebold
$5.33 /

+0.535 (+11.16%)

DBD Diebold
$5.33 /

+0.535 (+11.16%)

Conference/Events
Diebold participates in a conference call with Sidoti » 04:55
06/01/20
06/01
04:55
06/01/20
04:55
DBD

Diebold

$4.80 /

-0.515 (-9.70%)

Conference call with…

Conference call with management will be held on June 1 hosted by Sidoti.

ShowHide Related Items >><<
DBD Diebold
$4.80 /

-0.515 (-9.70%)

DBD Diebold
$4.80 /

-0.515 (-9.70%)

05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
DBD Diebold
$4.80 /

-0.515 (-9.70%)

DBD Diebold
$4.80 /

-0.515 (-9.70%)

DBD Diebold
$4.80 /

-0.515 (-9.70%)

Conference/Events
Diebold participates in a conference call with Sidoti » 12:31
05/27/20
05/27
12:31
05/27/20
12:31
DBD

Diebold

$5.42 /

+0.28 (+5.45%)

Conference call with…

Conference call with management will be held on June 1 hosted by Sidoti.

ShowHide Related Items >><<
DBD Diebold
$5.42 /

+0.28 (+5.45%)

DBD Diebold
$5.42 /

+0.28 (+5.45%)

05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
DBD Diebold
$5.42 /

+0.28 (+5.45%)

DBD Diebold
$5.42 /

+0.28 (+5.45%)

DBD Diebold
$5.42 /

+0.28 (+5.45%)

Upgrade
Diebold upgraded to Neutral on expense control at JPMorgan » 06:24
05/11/20
05/11
06:24
05/11/20
06:24
DBD

Diebold

$5.17 /

+0.15 (+2.99%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Coster upgraded Diebold Nixdorf to Neutral from Underweight with a price target of $7, up from $6. The analyst says he underestimated the company's commitment and ability to contain operating expenses in the second half of 2020. Coster now expects Diebold's expenses to decline in the second half relative to the first half and for its expense run-rate to be "somewhat contained" even into a year-over-year recovery in demand in 2021-2022. As such, there should be incremental leverage in the model and improved cash flow that will enable refinancing and lower interest charges, Coster tells investors in a research note.

ShowHide Related Items >><<
DBD Diebold
$5.17 /

+0.15 (+2.99%)

05/11/20 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
11/01/19 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
Upgrade
Diebold upgraded to Neutral from Underweight at JPMorgan » 04:42
05/11/20
05/11
04:42
05/11/20
04:42
DBD

Diebold

$5.17 /

+0.15 (+2.99%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Coster upgraded Diebold to Neutral from Underweight with a $7 price target.

ShowHide Related Items >><<
DBD Diebold
$5.17 /

+0.15 (+2.99%)

03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
11/01/19 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
09/17/19 Sidoti
Diebold initiated with a Buy at Sidoti
Hot Stocks
Diebold rises 22.7% » 12:00
05/05/20
05/05
12:00
05/05/20
12:00
DBD

Diebold

$5.41 /

+0.97 (+21.85%)

Diebold is up 22.7%, or…

Diebold is up 22.7%, or $1.00 to $5.40.

ShowHide Related Items >><<
DBD Diebold
$5.41 /

+0.97 (+21.85%)

03/27/20 JPMorgan
Diebold downgraded to Underweight with $6 price target at JPMorgan
03/27/20 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
11/01/19 JPMorgan
Diebold upgraded to Neutral from Underweight at JPMorgan
09/17/19 Sidoti
Diebold initiated with a Buy at Sidoti

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.